RobThatsMe
Well-known member
Hello Everyone,
I thought this worthy of posting, especially with so many now visiting the site world-wide.
Rob
Heart valve recall ordered after patient's death
Apr 15 (Reuters Health Spain) - Spain's Ministry of Health and Consumption has ordered the withdrawal from the market of artificial heart valves made by a Brazilian company after Italian health officials reported that the device was tied to a patient's death, ministry sources confirmed to Reuters Health Spain.
The valves are made by Brazil-based TRI Technologies.
Last Thursday, Italian health authorities alerted European Community countries of the death of a patient in whom a TRI valve had been implanted, the Spanish ministry told Reuters Health Spain.
One day later, the General Directorate of Pharmacy and Health Products advised the regions of the event and ordered the product's withdrawal.
The notice warns that "the autopsy report of the deceased patient in Italy points to a defect in the mechanical aortic valve that was implanted in the patient 11 days earlier," although the problem is not specified, official sources indicated to Reuters Health Spain.
According to ministry sources, to date the valve has been implanted in 13 Spaniards in three medical centers. Representatives at these centers informed Reuters Health Spain that the 13 heart patients were enrolled in a clinical trial begun in 2001 by the manufacturing company. The trial has been halted.
The 13 implanted patients are being monitored by cardiologists, who will decide "if it is warranted to subject the patients to a new operation to replace the prosthesis," the Ministry said.
The valve in question has not been approved by the US Food and Drug Administration.
© Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
HeartCenterOnline Commentary:
For additional information about artificial heart valves and other issues related to valvular heart disease, visit HeartCenterOnline's Heart Valve Center.
I thought this worthy of posting, especially with so many now visiting the site world-wide.
Rob
Heart valve recall ordered after patient's death
Apr 15 (Reuters Health Spain) - Spain's Ministry of Health and Consumption has ordered the withdrawal from the market of artificial heart valves made by a Brazilian company after Italian health officials reported that the device was tied to a patient's death, ministry sources confirmed to Reuters Health Spain.
The valves are made by Brazil-based TRI Technologies.
Last Thursday, Italian health authorities alerted European Community countries of the death of a patient in whom a TRI valve had been implanted, the Spanish ministry told Reuters Health Spain.
One day later, the General Directorate of Pharmacy and Health Products advised the regions of the event and ordered the product's withdrawal.
The notice warns that "the autopsy report of the deceased patient in Italy points to a defect in the mechanical aortic valve that was implanted in the patient 11 days earlier," although the problem is not specified, official sources indicated to Reuters Health Spain.
According to ministry sources, to date the valve has been implanted in 13 Spaniards in three medical centers. Representatives at these centers informed Reuters Health Spain that the 13 heart patients were enrolled in a clinical trial begun in 2001 by the manufacturing company. The trial has been halted.
The 13 implanted patients are being monitored by cardiologists, who will decide "if it is warranted to subject the patients to a new operation to replace the prosthesis," the Ministry said.
The valve in question has not been approved by the US Food and Drug Administration.
© Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
HeartCenterOnline Commentary:
For additional information about artificial heart valves and other issues related to valvular heart disease, visit HeartCenterOnline's Heart Valve Center.